# Adipose tissue–derived MFG-E8 promotes hepatic inflammation and fibrosis through macrophage activation in a mouse MASH model

**Authors:** Masashi Kuroda, Kazuhiro Nomura, Azumi Wada, Yui Hatano, Miki Ogawa, Saya Okamoto, Etsuko Ishikawa, Yuna Izumi-Mishima, Sonoko Yasui-Yamada, Yasuo M. Tsutsumi, Nagakatsu Harada, Rie Tsutsumi, Hiroshi Sakaue

PMC · DOI: 10.1038/s44324-026-00099-0 · 2026-02-20

## TL;DR

This study shows that a protein from fat tissue, MFG-E8, worsens liver inflammation and scarring in a mouse model of MASH by activating immune cells.

## Contribution

The study identifies MFG-E8 as a novel adipose-derived factor that promotes MASH progression through macrophage activation.

## Key findings

- MFG-E8 deficiency in MASH mice reduces inflammation and fibrosis-related gene expression.
- MFG-E8 supplementation intensifies hepatic inflammation and promotes crownlike structures in knockout mice.
- MFG-E8 enhances macrophage response to apoptotic hepatocytes, increasing inflammatory cytokine production.

## Abstract

Metabolic dysfunction–associated steatohepatitis (MASH) is characterized by hepatocellular injury, macrophage activation, and severe fibrosis, and often progresses to liver cirrhosis and hepatocellular carcinoma. Excessive accumulation of visceral fat exacerbates hepatic inflammation and fibrosis independently of fatty liver, but the underlying molecular mechanisms have remained unclear. We here identify MFG-E8 (milk fat globule–EGF8) as a secreted protein that is overexpressed in adipose tissue of obese mice and contributes to such exacerbation. MFG-E8 deficiency in MASH model (STAM-MASH) mice was associated with reduced hepatic expression of inflammation- and fibrosis-related genes without attenuation of steatosis. Conversely, MFG-E8 supplementation in MFG-E8 knockout mice intensified hepatic inflammation and promoted the formation of hepatic crownlike structures. Coculture of macrophages with apoptotic hepatocytes induced expression of inflammatory cytokine genes, and this effect was enhanced by the presence of exogenous MFG-E8 in the culture medium. Our findings suggest that adipose tissue–derived MFG-E8 infiltrates the liver and promotes macrophage-hepatocyte interaction, thereby contributing to hepatic inflammation and fibrosis in MASH.

## Linked entities

- **Genes:** MFGE8 (milk fat globule EGF and factor V/VIII domain containing) [NCBI Gene 4240]
- **Proteins:** MFGE8 (milk fat globule EGF and factor V/VIII domain containing)
- **Diseases:** MASH (MONDO:0007027), hepatocellular carcinoma (MONDO:0007256)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Mfge8 (milk fat globule EGF and factor V/VIII domain containing) [NCBI Gene 17304] {aka MFG-E8, MP47, Mfgm, P47, SED1, lactadherin}, Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}, Sp1 (trans-acting transcription factor 1) [NCBI Gene 20683] {aka 1110003E12Rik, Sp1-1}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Egf (epidermal growth factor) [NCBI Gene 13645], Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Mertk (MER proto-oncogene tyrosine kinase) [NCBI Gene 17289] {aka Eyk, Mer, Nyk, nmf12}, Timd4 (T cell immunoglobulin and mucin domain containing 4) [NCBI Gene 276891] {aka B430010N18Rik, TIM-4, Tim4}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}, Fcgr3 (Fc receptor, IgG, low affinity III) [NCBI Gene 14131] {aka CD16}, Mmp13 (matrix metallopeptidase 13) [NCBI Gene 17386] {aka Clg, MMP-13, Mmp1}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, Fcgr2b (Fc receptor, IgG, low affinity IIb) [NCBI Gene 14130] {aka CD32, F630109E10Rik, Fc[g]RII, FcgRII, Fcgr2, Fcgr2a}, Stam (signal transducing adaptor molecule (SH3 domain and ITAM motif) 1) [NCBI Gene 20844] {aka STAM1}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, Stab2 (stabilin 2) [NCBI Gene 192188] {aka FEEL-2, FELL, MFEEL-2, STAB-2}, Fcr (Fc receptor) [NCBI Gene 109615], Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Cd9 (CD9 antigen) [NCBI Gene 12527] {aka Tspan29}, Map3k5 (mitogen-activated protein kinase kinase kinase 5) [NCBI Gene 26408] {aka 7420452D20Rik, ASK, ASK1, MAPKKK5, Mekk5}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}
- **Diseases:** visceral adiposity (MESH:D007418), metabolic dysregulation (MESH:D021081), Fat (MESH:D004620), metabolic disorders (MESH:D008659), MRCD (MESH:D002796), hCLSs (MESH:D020914), obese (MESH:D009765), MASH (MESH:D005234), weight gain (MESH:D015430), chronic kidney disease (MESH:D051436), hepatic fibrosis (MESH:D008103), diabetic (MESH:D003920), cancer (MESH:D009369), NAFLD (MESH:D065626), cirrhosis (MESH:D005355), Inflammation (MESH:D007249), MASLD (MESH:D008107), liver tumors (MESH:D008113), dislocation (MESH:D004204), HCC (MESH:D006528), liver failure (MESH:D017093), hepatic (MESH:D056486), adiposity (MESH:D018205), type 2 diabetes (MESH:D003924), hCLS (MESH:D000072717), insulin (MESH:D007333), weight loss (MESH:D015431), lobular (MESH:D018275), adipocyte hypertrophy (MESH:D006984), cardiovascular disease (MESH:D002318), death (MESH:D003643)
- **Chemicals:** Blood glucose (MESH:D001786), cholesterol (MESH:D002784), SDS (MESH:D012967), biotin (MESH:D001710), Trizol (MESH:C411644), STZ (MESH:D013311), butorphanol (MESH:D002077), isoflurane (MESH:D007530), staurosporine (MESH:D019311), streptomycin (MESH:D013307), polyacrylamide (MESH:C016679), TG (MESH:D014280), 7-AAD (MESH:C025942), TritonX-100 (MESH:D017830), choline (MESH:D002794), EDTA (MESH:D004492), FITC (MESH:D016650), Nonidet P-40 (MESH:C010615), osmium tetroxide (MESH:D009993), troglitazone (MESH:D000077288), midazolam (MESH:D008874), sodium deoxycholate (MESH:D003840), NaCl (MESH:D012965), methionine (MESH:D008715), fat (MESH:D005223), Paraffin (MESH:D010232), formalin (MESH:D005557), glucose (MESH:D005947), polyvinylidene difluoride (MESH:C024865), eosin (MESH:D004801), 3,3'-diaminobenzidine (MESH:D015100), Tween 20 (MESH:D011136), PBS (MESH:D007854), lipid (MESH:D008055), CO2 (MESH:D002245), thioglycolate (MESH:D013864), fructose (MESH:D005632), PS (MESH:D010718), Fatty acids (MESH:D005227), isobutyl methylxanthine (MESH:D015056), dexamethasone (MESH:D003907), phenylmethylsulfonyl fluoride (MESH:D010664), Lipofectamine 2000 (MESH:C086724), puromycin (MESH:D011691), penicillin (MESH:D010406), hematoxylin (MESH:D006416), RGD (MESH:C047981), medetomidine (MESH:D020926), H2O2 (MESH:D006861), E8 (-)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123), He1c1c7 — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_9103), Hepa1c1c7 — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_0328), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12923611/full.md

---
Source: https://tomesphere.com/paper/PMC12923611